galactosamine has been researched along with ag-490 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anezaki, Y; Dohmen, T; Goto, T; Ishii, H; Kataoka, E; Ohnishi, H; Ohshima, S; Sato, W; Segawa, D; Shibuya, T; Takeuchi, S; Yamada, I; Yoneyama, K | 1 |
1 other study(ies) available for galactosamine and ag-490
| Article | Year |
|---|---|
Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure.
Topics: Animals; Apoptosis; Caspases; Cytokines; Disease Models, Animal; Ephedra sinica; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; STAT3 Transcription Factor; Tyrphostins | 2008 |